All In Biotech

Free tool

FAERS Monitor: Tikosyn

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020931 or its brand name (Tikosyn, Dofetilide). Reports on generic versions are filed under their own applications.

Reports

10,514

Serious

6,255

59% of reports

Hospitalization

3,009

Death reported

812

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • atrial fibrillation1,071
  • drug ineffective1,035
  • dyspnoea622
  • dizziness564
  • fatigue536
  • death485
  • electrocardiogram qt prolonged447
  • headache398
  • diarrhoea330
  • malaise323
  • drug interaction298
  • nausea296
  • asthenia294
  • heart rate increased289
  • arrhythmia268

Reports by year received

View as table
YearReports
2004249
2005196
2006156
2007118
200881
2009100
2010681
2011347
2012487
2013576
2014708
2015829
2016947
2017628
2018650
2019927
2020566
2021460
2022417
2023416
2024455
2025321
2026199

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,043,645 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
electrocardiogram qt prolongedSignal44725.223.010,237
atrial fibrillationSignal1,07122.221.021,558
arrhythmiaSignal26811.410.12,518
heart rate increasedSignal2895.85.21,159
drug interactionSignal2983.83.4605
dizzinessSignal5642.32.1406
dyspnoeaSignal6222.22.0416
drug ineffective1,0351.61.5229
asthenia2941.61.460
malaise3231.51.350
fatigue5361.41.357
headache3981.31.223
death4851.11.07
diarrhoea3301.00.90
nausea2960.70.726

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.